MPR

Countries Involved in US Clinical Trials Do Not Gain Timely Access to Approved Medicines

HealthDay News — Most countries involved in clinical trials for US Food and Drug Administration approvals do not gain timely physical access to the medicines that they help evaluate, according to a ...
MPR

New Measles Spread Across States Threatens US Elimination Status

Countries lose measles elimination status when the same strain spreads for 12 months or more. If transmission continues into January (the 1-year mark) the US could lose the designation it has held for ...
MPR

Novo Nordisk Rolls Out Lower Prices for Ozempic and Wegovy

HealthDay News — People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications. The company announced that ...
MPR

Mixed Results for Mitapivat in Sickle Cell Disease Trial

Agios Pharmaceuticals plans to share data from RISE UP with the Food and Drug Administration to support the approval of the sickle cell disease indication.
MPR

Doravirine/Islatravir Noninferior to BIC/FTC/TAF in Treatment-Naïve Adults With HIV-1

The investigational oral therapy combines doravirine, a non-nucleoside reverse transcriptase inhibitor, with islatravir, a nucleoside reverse transcriptase translocation inhibitor, in a single tablet ...
MPR

FDA Approves Redemplo for Familial Chylomicronemia Syndrome

Plozasiran is an apoC-III-directed small interfering ribonucleic acid designed to reduce levels of hepatic and serum apoC-III ...
MPR

Recommendations Developed for Managing Community-Acquired Pneumonia in Adults

Lung ultrasound is acceptable diagnostic alternative to chest radiography in medical centers with appropriate clinical expertise.
MPR

Hypnosis May Reduce Hot Flashes in Postmenopausal Women

Study reveals self-administered, at-home hypnosis intervention reduces mean number of hot flashes, daily interference.
MPR

More US Adults Dying Before Realizing Medicare Benefits

Irene Papanicolas, PhD, from the Brown University School of Public Health in Providence, Rhode Island, and colleagues calculated premature mortality rates across US states and Washington, DC, for 2012 ...
MPR

Risks for Vascular, Inflammatory Diseases Increased for Children After COVID-19

COVID-19 diagnosis linked to higher risk for arterial thromboembolism, venous thromboembolism, thrombocytopenia, myocarditis or pericarditis ...
MPR

Washington Reports First Human Case of Rare Bird Flu Strain

HealthDay News — A Washington state resident has become the first person in the US to test positive for a rare bird flu strain that has never before been found in humans. The older adult, who has ...
MPR

Thrombate III Approved for Hereditary Antithrombin Deficiency in Children

With this approval, Thrombate III is the only antithrombin concentrate approved in both adults and pediatric patients with hereditary antithrombin deficiency.